Despite isolated reports suggesting possible human-to-human transmission of the Andes virus, experts urged caution in drawing conclusions about its pandemic potential based on limited observations.

"Our results suggest that a 10-day course of moxifloxacin 400 mg daily could be used as a first-line regimen to treat MG infections in settings where assessment of resistance-associated mutations is ...

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this ...

According to a post hoc analysis of patients with juvenile idiopathic arthritis on tofacitinib, younger patients have higher height velocities than expected, and older patients have normal velocities.

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

A vaccinated woman in her fifties rapidly improved on ensitrelvir but had symptomatic and virologic rebound 1 day after completing therapy — quantitative antigen rose markedly from ~145 pg/mL at ...

Those are some of the questions dermatologists face when a patient on systemic therapy for psoriasis does not respond fully, when the patient reacts favorably at first but then treatment effectiveness ...

Patients with rheumatoid arthritis (RA) and preserved kidney function who started reduced doses of JAK inhibitors had treatment persistence and disease control that were similar to those in patients ...

Denver — Thanks to treatments approved by the FDA in recent years, pediatric dermatologists’ strategy for epidermolysis bullosa (EB) has shifted from providing supportive care to correcting underlying ...

TORONTO — Currently available drugs to treat patients with axial spondyloarthritis (axSpA) are generally effective for symptom control, and many also for structural protection, but not everyone ...